DBV Technologies (DBVT) Long-Term Investments (2015 - 2019)
DBV Technologies (DBVT) reported Long-Term Investments of $18.3 million for Q4 2019, up 165.03% year-over-year from $6.9 million in Q4 2018, and up 165.03% quarter-over-quarter from $6.9 million in Q4 2018.
DBV Technologies (DBVT) Long-Term Investments (2015 - 2019) Analysis & Trends
DBV Technologies (DBVT) has 5 years of Long-Term Investments data on file, last reported at $18.3 million in Q4 2019.
- Long-Term Investments for Q4 2019 came in at $18.3 million, up 165.03% year-over-year; the trailing twelve-month figure through Dec 2019 was $18.3 million (up 165.03% YoY), and the FY2019 annual result was $18.3 million, up 165.03% from the prior year.
- Long-Term Investments climbed to $18.3 million in Q4 2019 per DBVT's latest filing, from $6.9 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $18.3 million in Q4 2019 and troughed at $3.0 million in Q4 2016.
- A 5-year average of $6.9 million and a median of $3.5 million in 2017 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2016 and 2019: Long-Term Investments dropped 0.26% in 2016, then surged 165.03% in 2019.
- A 5-year view of Long-Term Investments shows it stood at $3.0 million in 2015, then declined by 0.26% to $3.0 million in 2016, then grew by 19.66% to $3.5 million in 2017, then surged by 94.17% to $6.9 million in 2018, then surged by 165.03% to $18.3 million in 2019.
- Business Quant data shows DBVT's Long-Term Investments at $18.3 million in Q4 2019, $6.9 million in Q4 2018, and $3.5 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 18.25 Mn |
| Dec 31, 2018 | 6.89 Mn |
| Dec 31, 2017 | 3.55 Mn |
| Dec 31, 2016 | 2.96 Mn |
| Dec 31, 2015 | 2.97 Mn |